In a study by Antonia et al., patients with extensive stage small cell lung cancer were treated with a combination of chemotherapy (cisplatin/VP-16, carboplatin/VP-16, or cisplatin/CPT-11) and p53 cancer vaccine (DCs with adenoviral transduction of p53) [80]. The gene discussed is TP53; the disease is small cell lung carcinoma.